Burden of chronic kidney disease in resource-limited settings from Peru: A population-based study

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Francis, Elizabeth R ^a,b,c,d   Kuo, Chin Chi ^c,e   Bernabe Ortiz, Antonio ^d,f   Nessel, Lisa ^g   Gilman, Robert H ^c,d,h   Checkley, William ^c,d,i   Miranda, J Jaime ^d,f   Feldman, Harold I ^g  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CRONICAS CENTER OF EXCELLENCE IN CHRONIC DISEASES   (Peru)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h ASOCIACIÓN BENÉFICA PRISMA   (Peru)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic diseases; Chronic kidney disease; Prevalence

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GEOGRAPHIC DISTRIBUTION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH CARE UTILIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERU; POPULATION RESEARCH; PREVALENCE; PROTEINURIA; RESIDENTIAL AREA; RISK FACTOR; SEX DIFFERENCE; SOCIAL STATUS; URBAN AREA; AGED; DYSLIPIDEMIAS; HEALTH CARE PLANNING; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; URBAN POPULATION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HEALTH RESOURCES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERU; PREVALENCE; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; URBAN POPULATION;

EID: 84937949010     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0104-7     Document Type: Article

References (44)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31-40.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23.
3. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378:804-14.
4. Andrassy KM. Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease'. Kidney Int. 2013;84:622-3.
5. World Health Orgnization. Investing in health for economic developement. Commission on Macroeconomics and Health. Geneva: World Health Orgnization; 2001.
6. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85-97.
7. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med. 2007;356:213-5.
8. Huynen MM, Vollebregt L, Martens P, Benavides BM. The epidemiologic transition in Peru. Revista Panamericana de Salud Pública. 2005;17:51-9.
9. Alcalde-Rabanal JE, Lazo-González O, Nigenda G. Sistema de salud de Perú. Salud Publica Mex. 2011;53:S243-54.
10. Dirks JH, Robinson S, Burdmann E, Correa-Rotter R, Mezzano S, Rodriguez-Iturbe B. Prevention strategies for chronic kidney disease in Latin America: a strategy for the next decade - a report on the Villarica Conference. Ren Fail. 2006;28:611-5.
11. Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007;450:494-6.
12. Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011;97:787-96.
13. Jacoby E, Goldstein J, López A, Núñez E, López T. Social class, family, and life-style factors associated with overweight and obesity among adults in Peruvian cities. Prev Med. 2003;37:396-405.
14. McKeown RE. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med. 2009;3:19S-26.
15. Cieza J, Huamán C, Alvarez C, Gómez J, Castillo W. Prevalencia de insuficiencia renal crónica en la ciudad de Lima-Perú, Enero 1990. Rev Peru Epidemiol. 1992;5:22-7.
16. Carlini R, Obrador G, Campistrús N, Andrade L, Chifflet L, Bregman R, et al. The first report of The Latin American Society of Nephrology and Hypertension (SLANH) anemia committee in chronic hemodialysis patients. Nefrología (Madrid). 2014;34:96-104.
17. Cusumano AM, Di Gioia C, Hermida O, Lavorato C; Latin American Registry of Dialysis and Renal Transplantation. The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002. Kidney Int Suppl. 2005: S46-52.
18. Cusumano AM, Garcia-Garcia G, Gonzalez-Bedat MC, Marinovich S, Lugon J, Poblete-Badal H, et al. Latin American Dialysis and Renal Transplant Registry: 2008 report (data 2006). Clin Nephrol. 2010;74 Suppl 1:S3-8.
19. Miranda JJ, Bernabe-Ortiz A, Smeeth L, Gilman RH, Checkley W; CRONICAS Cohort Study Group. Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ open. 2012;2:e000610.
20. LIoyd P. The 'young towns' of Lima: Aspects of urbanization in Peru. Cambridge: Cambridge University Press; 1980.
21. World Health Orgnization. The WHO STEPwise approach to chronic disease risk factor surveillance (STEPS). Geneva: World Health Orgnization; 2009.
22. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-12.
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26 Suppl 1:S5-20.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
26. National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
27. Howe LD1, Galobardes B, Matijasevich A, Gordon D, Johnston D, Onwujekwe O, et al. Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol. 2012;41:871-86.
28. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
29. Hosseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9:44.
30. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-47.
31. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379:815-22.
32. Nagata M, Ninomiya T, Doi Y, Yonemoto K, Kubo M, Hata J, et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant. 2010;25:2557-64.
33. Kim S, Lim CS, Han DC, Kim GS, Chin HJ, Kim SJ, et al. The prevalence of chronic kidney disease (CKD) and the associated factors to CKD in urban Korea: a population-based cross-sectional epidemiologic study. J Korean Med Sci. 2009;24(Suppl):S11-21.
34. Ordunez P, Saenz C, Martinez R, Chapman E, Reveiz L, Becerra F2. The epidemic of chronic kidney disease in Central America. Lancet Glob Health. 2014;2:e440-1.
35. Gracia-Trabanino R, Domínguez J, Jansà JM, Oliver A. Proteinuria and chronic renal failure in the coast of El Salvador: detection with low cost methods and associated factors. Nefrologia. 2005;25:31-8.
36. O'Donnell JK, Tobey M, Weiner DE, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant. 2011;26:2798-805.
37. Cusumano AM, Gonzalez Bedat MC. Chronic kidney disease in Latin America: time to improve screening and detection. Clin J Am Soc Nephrol. 2008;3:594-600.
38. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-100.
39. Carrero JJ. Gender differences in chronic kidney disease: underpinnings and therapeutic implications. Kidney Blood Press Res. 2010;33:383-92.
40. Hossain MP, Goyder EC, Rigby JE, El Nahas M. CKD and poverty: a growing global challenge. Am J Kidney Dis. 2009;53:166-74.
41. Instituto Nacional de Estadística e Informática. Sistema de Difusión de los Censos Nacionales. Censos de Población y Vivienda 2007, vol. 2014. Lima: INEI; 2007.
42. Weiner DE, McClean MD, Kaufman JS, Brooks DR. The Central American epidemic of CKD. Clin J Am Soc Nephrol. 2013;8:504-11.
43. Ghahramani N, Ahmed F, Al-Laham A, Lengerich EJ. The epidemiological association of altitude with chronic kidney disease: Evidence of protective effect. Nephrology. 2011;16:219-24.
44. Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58:635-41.